Inositol triphosphate participates in an oestradiol nongenomic signalling pathway involved in accelerated oviductal transport in cycling rats
No Thumbnail Available
Date
2006
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Oestradiol (E,) accelerates oviductal transport of oocytes in cycling rats through a nongenomic pathway that involves the cAMP-PKA signalling cascade. Here we examined the role of the inositol triphosphate (IP3) and mitogen-activated protein kinase (MAPK) signalling cascades in this nongenomic pathway. Oestrous rats were injected with E-2 s.c. and intrabursally (i.b) with the selective inhibitors of phospholipase C (PLC) ET-18OCH(3) or MAPK PD98059. The number of eggs in the oviduct assessed 24 h later showed that ET-18-OCH3 blocked E-2-induced egg transport acceleration, whereas PD980559 had no effect. Other oestrous rats were treated with E-2 s.c. and 1, 3 or 6 h later oviducts were excised and the levels of IP3 and phosphorylated MAPK p44/42 (activated) were determined by radioreceptor assay and Western blot, respectively. Oestradiol administration increased IP3 level at 1 and 6 h after treatment, whereas activated MAPK p44/42 level was unchanged. Finally, e 0 1 we explored whether cAMP-PKA and PLC-IP3 signalling cascades are coupled. Inhibition of adenylyl cyclase by i.b. injection of SQ 22536 blocked the increase of IP3 levels induced by E, while inhibition of PLC by ET-18OCH(3) had no effect on E(2-)induced PKA activity. Furthermore, activation of adenylyl cylase by Forskolin increased oviducral IP3 levels. Thus, activation of PLC-IP3 by E, requires previous stimulation of cAMP-PKA. We conclude that the nongenomic pathway utilised by E, to accelerate oviductal transport of oocytes in cycling rats involves Successive activation of the cAMP-PKA and PLC-IP3 signalling cascades and does not require activation of MAPK. These findings clearly illustrate a non-genomic pathway triggered by E-2 that regulates a complex physiologic process accomplished by in entire organ.